AGE Serum Safety and Effectiveness in Post-Menopausal Women on GLP-1 Medication
Part of Genetic & congenital, Skin clinical trials.
This study tests a new facial serum (AGE Serum) designed to improve signs of aging like fine lines and loose skin in post-menopausal women who are taking GLP-1 medications (like Ozempic or Wegovy). Researchers want to see if it's safe and if it actually works to improve how the skin looks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a post-menopausal woman aged 45–65 years old
- You have mild to moderate facial aging signs like fine lines, wrinkles, loose skin, or dull texture
- You have been taking a stable dose of a GLP-1 medication (Ozempic, Rybelsus, or Wegovy) for at least 3 months
- You have not had facial cosmetic procedures (lasers, injectables, microneedling, etc.) in the past 1–12 months, depending on the procedure type
- You are in generally good health with no uncontrolled diseases or active skin infections
- You are willing to have photos taken and complete the full study course
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a topical serum designed to improve visible signs of facial aging, such as fine lines and skin texture. It is looking specifically at men and women aged 25–50 who are already taking a GLP-1 medication like Ozempic, and want to see if adding this serum helps their skin look younger.
This study tests whether injections of poly-L-lactic acid (a collagen-boosting filler) can improve loose skin on the belly in women taking or not taking GLP-1 medications (like Ozempic or Wegovy). It aims to help people who have mild to moderate loose skin and are at a stable weight.
This trial tests a new injectable collagen product called MEC REGENERATE® to see if it is safe and works well for improving the appearance of facial skin. It may be an option if you are looking for a non-surgical aesthetic treatment.
This trial tests whether a hyaluronic acid filler (a gel injected into the skin) can improve skin quality in women who are taking or not taking GLP-1 medications (like Ozempic or Wegovy). It aims to see if the filler helps with skin radiance, elasticity, tone, firmness, fine lines, wrinkles, and smoothness.
This early-phase trial tests whether injections of a substance called secretome can improve facial aging by reducing wrinkles and improving skin elasticity and texture. Participants receive multiple injections over several visits and must be willing to follow a strict skincare routine and avoid other cosmetic procedures during the study.
This trial tests whether a supplement called GLYLO can reduce markers of aging related to sugar damage in postmenopausal women. It may help if you are between 45 and 65, have some extra belly fat or higher blood sugar, and are not taking certain medications.
Hear when a new Laxity; Skin trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.